Pembrolizumab May Be Preferable to Chemo in Certain Patients
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […]
Microsatellite Instability